Huh Seung Jae, Nishimura Tetsuo, Park Won, Onishi Hiroshi, Ahn Yong Chan, Nakamura Katsumasa
Department of Healthcare Review and Assessment, Health Insurance Review and Assessment Service, Wonju, Korea.
Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Radiat Oncol J. 2020 Sep;38(3):170-175. doi: 10.3857/roj.2020.00703. Epub 2020 Sep 25.
This study aimed to compare the current status of the national health insurance system (HIS) for advanced radiation technologies in Korea and Japan.
The data of the two nations were compared according to the 2019 guidelines on the application and methods of medical care benefit from the Ministry of Health and Welfare of Korea and the 2020 medical fee points list set by the Ministry of Health, Labor and Welfare of Japan.
Both countries have adopted the social insurance system and the general payment system which is fee-for-service for radiotherapy. However, for proton and carbon ion therapy, the Japanese system has adopted a bundled payment system. Copayment for radiotherapy is 5% in Korea and 30% (7-69 years old) in Japan, with a ceiling system. A noticeable difference is that additional charges for hypofractionation, tele-radiotherapy planning for an emergency, tumor motion-tracking, purchase price of an isotope purchase price, and image-guided radiotherapy are allowed for reimbursement in the Japanese system. There are some differences regarding the indication, qualification standards, and facility standards for intensity-modulated radiation therapy, stereotactic body radiation therapy, and proton therapy.
Patterns of cancer incidence, use of radiotherapy and infrastructure, and national HIS are very similar between Korea and Japan. However, there are some differences in health insurance management systems for advanced radiation technologies.
本研究旨在比较韩国和日本国家医疗保险体系(HIS)中先进放射技术的现状。
根据韩国卫生与福利部2019年医疗护理福利申请及方法指南以及日本厚生劳动省2020年医疗费用点数表对两国数据进行比较。
两国均采用社会保险制度和放疗按服务收费的一般支付制度。然而,对于质子和碳离子治疗,日本系统采用了捆绑支付制度。韩国放疗的自付费用为5%,日本为30%(7至69岁),设有上限制度。一个显著差异是,日本系统允许对超分割、紧急远程放疗计划、肿瘤运动追踪、同位素购买价格以及图像引导放疗的额外费用进行报销。在调强放射治疗、立体定向体部放射治疗和质子治疗的适应症、资格标准和设施标准方面存在一些差异。
韩国和日本在癌症发病率模式、放疗使用情况和基础设施以及国家医疗保险体系方面非常相似。然而,在先进放射技术的医疗保险管理系统方面存在一些差异。